TransMedics Group, Inc. Common Stock

TMDXNASDAQUSD
69.93 USD
1.00 (1.44%)🟢PRE MARKET (AS OF 05:06 AM EDT)
🟢Market: OPEN
Open?$68.72
High?$69.93
Low?$68.72
Prev. Close?$68.94
Volume?2.1K
Avg. Volume?1.6M
VWAP?$69.83
Rel. Volume?0.00x
Bid / Ask
Bid?$59.87 × 100
Ask?$78.81 × 100
Spread?$18.94
Midpoint?$69.34
Valuation & Ratios
Market Cap?2.4B
Shares Out?34.6M
Float?33.1M
Float %?96.4%
P/E Ratio?13.86
P/B Ratio?4.82
EPS?$4.97
Dividend?0.00%
Ex-Dividend?N/A

Shares of TransMedics Group, Inc. Common Stock (TMDX) are trading at $69.93. The stock presents a bearish profile across the board: technical indicators signal "Sell" and our fundamental models agree with a "Sell" rating. Notable factors include exceptional Return on Equity (34.8%), a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. Valuation metrics place TMDX at a fair price relative to peers.

Technical & fundamental data as of May 26, 2026.

News
Profile
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System (OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization, and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.
Employees
898
Market Cap
2.4B
Industry
ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
Listed
2019-05-02
Address
200 MINUTEMAN ROAD
ANDOVER, MA 01810
Phone: (978) 552-0900
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)? Bearish(-2/3)
Medium-Term (Wave)? Neutral(0/3)
Short-Term (Ripple)? Bullish(+2/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
40
Z-Score?
48
Momentum?
33
Short Sent.?
31
Piotroski F-Score?4/9Mixed
Altman Z-Score?2.36Grey
Confidence?79%Moderate
Full Fundamental Analysis →
Short InterestSqueeze Risk
Short % of Float?25.16%Squeeze Risk
Short Interest?8.3M
Days to Cover?8.6
Free Float33.1M
Avg Daily Volume965.9K
Settlement Date2026-04-30
Financial Health
Current Ratio?6.74Strong
Quick Ratio?6.19Strong
Cash Ratio?5.02Strong
Debt/Equity?1.73High
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
72/100
P/E?
Peers
100
S&P
85
13.9CHEAP
P/B?
Peers
100
S&P
38
4.82FAIR
P/S?
Peers
100
S&P
41
3.75FAIR
P/FCF?
Peers
100
S&P
71
15.7CHEAP
EV/EBITDA?
Peers
100
S&P
20
21.8HIGH
EV/Sales?
Peers
100
S&P
42
4.37FAIR
Returns & Efficiency
ROE?
Peers
50
S&P
83
34.8%STRONG
ROA?
Peers
50
S&P
80
12.0%STRONG
Cash Flow & Enterprise
FCF?$151.4M
Enterprise Value?$2.8B
Fundamentals ratios updated end of day